Adverse Side Effects of Psychotropic Medication and Challenging Behavior: Pilot Work Assessing Impact.
Adverse Side Effects of Psychotropic Medication and Challenging Behavior: Pilot Work Assessing Impact.
复制标题
精神药物的不良副作用和挑战行为：试点工作评估影响。
DOI：
10.1007/s10882-017-9570-0
复制
发表时间：
2017
影响因子：
1.8
通讯作者：
Carpenter,Jaimie
中科院分区：
文献类型：
--
作者：
Valdovinos,MariaG;Schieber,Elizabeth;McMahon,Meara;Beard,Lisa;Wilkinson,Alyssa;Carpenter,Jaimie
精神药物通常是为了减少智力和发育障碍(IDD)患者的挑战性行为而开的。功能分析(FA)已经证明在评估药物对行为的影响方面是有用的；然而，不良副作用(ASE)对挑战性行为的影响被低估了。这项研究的目的是开发一种类似于FAs的方法学，以探索药物对7名IDD患者挑战行为的潜在影响。结果显示，大多数参与者在设计的ASE条件下的应答率存在差异。结果支持进一步开发和使用这一方法来评估ASES的存在和影响。
Psychotropic medications are often prescribed to reduce challenging behavior in individuals with intellectual and developmental disabilities (IDD). Functional analyses (FAs) have demonstrated utility in assessing medication impact on behavior; however, the impact of adverse side effects (ASE) on challenging behavior is under-assessed. The purpose of this study was to develop a methodology, similar to FAs, to explore potential medication ASE impact on challenging behavior in seven individuals with IDD. Results revealed response rate differences in designed ASE conditions for most participants. Outcomes support further development and use of this methodology to assess the presence and impact of ASEs.